Mydecine Innovations Group Inc. (CSE:MYCO)

Market Cap	553.87K
Revenue (ttm)	n/a
Net Income (ttm)	220.73K
Shares Out	n/a
EPS (ttm)	0.00
PE Ratio	2.51
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,929
Average Volume	28,880
Open	0.0100
Previous Close	0.0050
Day's Range	0.0100 - 0.0100
52-Week Range	0.0050 - 0.0150
Beta	2.38
RSI	53.90
Earnings Date	Aug 20, 2025

About CSE:MYCO

Mydecine Innovations Group Inc., a biotechnology company, engages in the research, development, and commercialization of psilocybin products to treat mental health conditions. The company primarily focuses on treating nicotine addiction and post-traumatic stress disorder. It also develops MYCO-005, MYCO-006, and MYCO-007 for MDMA and psilocybin analogs. The company has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds. Mydecine Innovations...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2013
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: MYCO